TY - JOUR T1 - The ‘CURE IT’ programme – introducing equity, removing barriers, and treating patients with hepatitis C close to home: the Queensland experience JF - Future Healthcare Journal JO - Future Healthc J SP - s16 LP - s16 DO - 10.7861/fhj.7.1.s16 VL - 7 IS - Suppl 1 AU - Hayley Thompson AU - Tony Rhaman AU - Myat Lin Lei Y1 - 2020/02/01 UR - http://www.rcpjournals.org/content/7/Suppl_1/s16.abstract N2 - Healthcare delivery in Queensland has geographical challenges including distance, transport and distribution of specialists and services. Hepatitis C virus (HCV) affects approximately 230,000 people in Australia. In 2016, the Pharmaceutical Benefits Scheme facilitated primary care prescribing of the new direct-acting antivirals (DAAs). Traditional HCV treatment occurred in tertiary hospitals, requiring patient travel, multiple attendances and missed appointments.The ‘CURE IT’ programme facilitates a shared model of care between community prescribers and hospital specialists, while providing clinical, financial and a best … ER -